Pricing Log in Create free account

Ernexa Therapeutics Inc. (ERNA) vs Jupiter Neurosciences, Inc. (JUNS)

Ernexa Therapeutics Inc. and Jupiter Neurosciences, Inc. are both Biotechnology companies. Ernexa Therapeutics Inc. and Jupiter Neurosciences, Inc. are of similar size ($3.0M and $2.8M). Across the 7 metrics below, Ernexa Therapeutics Inc. leads on 6 and Jupiter Neurosciences, Inc. on 1.

Valuation

Metric ERNA JUNS Biotechnology median
P/E n/m n/m 10.60
P/S 3.82 n/m 9.40
P/B 0.70 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.01 0.66
EV/Sales 50.76 n/m 9.02
Earnings yield (992.55%) (842.19%) (32.88%)
Free cash flow yield (399.18%) (572.73%) (23.13%)

Profitability

Metric ERNA JUNS Biotechnology median
Gross margin 83.51% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (321.22%) (1,888.80%) (51.96%)
Return on assets (176.62%) (239.36%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ERNA JUNS Biotechnology median
Revenue growth (TTM) (78.60%) — 6.76%
EPS growth (last fiscal year) 95.42% (212.50%) 29.88%
Revenue growth, 5-year CAGR (52.20%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ERNA JUNS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.01 0.66 4.97
Net debt to EBITDA 0.21 0.43 1.01

Dividend

Metric ERNA JUNS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ERNA JUNS Biotechnology median
Market cap 2.99m 2.81m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack